Skip to content

Effect of Yoga in patients with Somatoform pain disorders

A study of therapeutic effect of Yoga- based intervention in patients with Somatoform pain disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014375
Enrollment
120
Registered
2018-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Somatoform pain disorders

Interventions

Intervention1: Yoga protocol for Somatoform pain disorders: A validated module for somatoform pain disorder has been developed which has a combination of Asana, Pranayama and Dhyana. Control Intervent

Sponsors

AYUSH Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria â?? ICD 10 diagnosis of Somatoform disorders with predominant pain component on clinical evaluation. Written informed consent

Exclusion criteria

Exclusion criteria: Mental retardation Current substance dependence other than nicotine Psychosis Comorbid Severe depression. Hypochondriasis Pregnant / lactating / postpartum women Significant medical co-morbidity (Such as known neurological illness, and medical illnesses which can challenge Postures(Asanas)in orthopedic flexion deformities, arthritis or connective tissue diseases) Contraindications for each asanas will be assessed and ruled out by clinical examination by qualified medical practitioner.

Design outcomes

Primary

MeasureTime frame
Visual Analogue ScaleTimepoint: baseline 2weeks 6weeks 12 weeks 24 weeks

Secondary

MeasureTime frame
scale for assessment for somatic (SASS)symptoms,Visual analogue scale(VAS),Brief pain inventory(BPI),Clinical global impression(CGI),WHO quality of life BREF(WHO QOL BREF),Hamilton anxiety rating scale(HAM A), hamilton depression rating scale(HAM D), world health organization disability assessment schedule 2.0.(WHO DAS) Blood sample for pro inflammatory markers(IL1 beta,IL6,THF alpha,CRP Neopterin)Timepoint: baseline assessments: SASS, VAS, BPI, WHO QOL BREF, HAM A,HAM D, WHO DAS 2.0 Assessment at 2 weeks- VAS yoga rating scale assessment at 6 weeks- VAS,yoga rating scale and BPI assessment at 12 weeks -SASS,VAS,CGI,BPI,WHO QOL BREF,HAM A, HAM D, WHO DAS assessment at 24 weeks - VAS BPI

Countries

India

Contacts

Public ContactDr Geetha Desai

NIMHANS

desaigeetha@nimhans.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026